Literature DB >> 670885

The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxin and toxoid in rats.

N F Pierce.   

Abstract

This report describes studies of the mucosal antitoxic response in rats after enteric administration of several forms of cholera toxin or toxoid, proteins which differ primarily in their ability to bind to cell membranes and activate cellular adenyl cyclase. These two characteristics appeared to markedly enhance the local primary response to these antigens. A single dose of toxoid lacking these features was ineffective in local priming even though it was absorbed and induced a systemic immune response. Single dose mucosal priming occurred only with preparations which bind to cell membranes and was enhanced by those which also activate cellular adenyl cyclase. In contrast, single-dose mucosal boosting was best accomplished by materials with these properties but was also seen with a toxoid lacking both of these functions. The property of membrane binding appears to be most advantageous in mucosal priming, perhaps by increasing effective trapping of absorbed antigen in unprimed mucosal lymphoid tissue, whereas the ability to activate adenyl cyclase appears to enhance primary and secondary type responses about equally. Combinations of crude toxoid and toxin were also more effective in mucosal priming than purified materials, a finding which is unexplained. A single dose of this combination induced mucosal priming which was fully developed in 2 wk, undiminished after 4 too, and only modestly diminished after 8 mo, thus demonstrating relatively prolonged memory in the IgA mucosal immune system. Effective two-dose local immunizing regimens were developed, and it was shown that there was no correlation between the mucosal and systemic secondary antitoxin responses provoked by these regimens.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 670885      PMCID: PMC2184905          DOI: 10.1084/jem.148.1.195

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Cholera toxin, ganglioside receptors and the immune response.

Authors:  J Holmgren; L Lindholm
Journal:  Immunol Commun       Date:  1976

2.  Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique.

Authors:  P Brandtzaeg
Journal:  Immunology       Date:  1974-06       Impact factor: 7.397

3.  In vitro correction of antigen-induced immune suppression: effects of histamine, dibutyryl cyclic AMP and cholera enterotoxin.

Authors:  E Mozes; Y Weinstein; H R Bourne; K L Melmon; G M Shearer
Journal:  Cell Immunol       Date:  1974-03-30       Impact factor: 4.868

4.  Vibrio cholerae choleragenoid. Mechanism of inhibition of cholera toxin action.

Authors:  P Cuatrecasas
Journal:  Biochemistry       Date:  1973-08-28       Impact factor: 3.162

5.  Activation of adenylate cyclase by cholera toxin in rat liver homogenates.

Authors:  J Flores; P Witkum; G W Sharp
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

6.  Cyclic AMP and immune responses. I. Influence of poly A:U and cAMP on antibody formation in vitro.

Authors:  M Ishizuka; W Braun; T Matsumoto
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

7.  Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins.

Authors:  D V Kimberg; M Field; J Johnson; A Henderson; E Gershon
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

8.  Cellular kinetics of the intestinal immune response to cholera toxoid in rats.

Authors:  N F Pierce; J L Gowans
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

9.  Functional characteristics of Peyer's patch lymphoid cells. I. Induction of humoral antibody and cell-mediated allograft reactions.

Authors:  M F Kagnoff; S Campbell
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

10.  Antibodies of the IgA type in intestinal plasma cells of germfree mice after oral or parenteral immunization with ferritin.

Authors:  P A Crabbé; D R Nash; H Bazin; D V Eyssen; J F Heremans
Journal:  J Exp Med       Date:  1969-10-01       Impact factor: 14.307

View more
  53 in total

1.  Differential effect of cholera toxin on CD45RA+ and CD45RO+ T cells: specific inhibition of cytokine production but not proliferation of human naive T cells.

Authors:  K Eriksson; I Nordström; C Czerkinsky; J Holmgren
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Difference between bacterial and food antigens in mucosal immunogenicity.

Authors:  A E Wold; U I Dahlgren; L A Hanson; I Mattsby-Baltzer; T Midvetdt
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

3.  Cholera toxin as a mucosal adjuvant: effects of H-2 major histocompatibility complex and lps genes.

Authors:  C O Elson
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

4.  Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.

Authors:  M W Russell; H Y Wu
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity.

Authors:  R A Kay; A Ferguson
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

6.  Enhanced mucosal priming by cholera toxin and procholeragenoid with a lipoidal amine adjuvant (avridine) delivered in liposomes.

Authors:  N F Pierce; J B Sacci
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

7.  Local and systemic immune response to orally administered liposome-associated soluble S. mutans cell wall antigens.

Authors:  D Wachsmann; J P Klein; M Schöller; R M Frank
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

8.  A role for intestinal T lymphocytes in bronchus mucosal immunity.

Authors:  F J Wallace; A W Cripps; R L Clancy; A J Husband; C S Witt
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

9.  Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.

Authors:  R E Black; M M Levine; M L Clements; C R Young; A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

10.  Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory.

Authors:  P F Wright; B R Murphy; M Kervina; E M Lawrence; M A Phelan; D T Karzon
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.